Industry Research Reports

Home > Reports > Medical Devices & Consumables > Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-03-05

Pages: 108 Pages

Report ld: 6015898

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size(US$)

CAGR 2026-2032

11.3%

Market Size,2032

USD 3,603

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,896 million

Market Forecast in 2032(Value)

US$ 3,603 million

CAGR

11.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1721 million in 2025 and is projected to reach US$ 3603 million, growing at a CAGR of 11.3% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Micro Invasive Glaucoma Surgery (MIGS) Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Glaucoma is a disease characterized by optic disc atrophy and depression, visual field loss, and decreased vision. Impaired aqueous humor circulation in the eye causes elevated intraocular pressure (IOP), exceeding the optic nerve's tolerance, leading to chronic optic nerve damage. With the aging population, the number of glaucoma patients is increasing annually.

MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.Therefore, it has attracted considerable attention in the glaucoma treatment field and holds promising clinical application prospects. It has become a popular market segment for many ophthalmic medical device companies.

The market for minimally invasive glaucoma surgery (MIGS) devices is experiencing rapid growth. This growth is primarily driven by the clinical needs of 80 million glaucoma patients worldwide, an aging population, and increased healthcare coverage. Currently, the market is dominated by trabecular meshwork drainage devices (such as the iStent), accounting for 38% of the market share, but subconjunctival drainage (XEN Gel Stent) and suprachoroidal drainage (Hydrus) technologies are rapidly gaining market share. North America holds nearly 60% of the global market, followed closely by Europe. The Asia-Pacific region (particularly China) holds significant potential due to localized production and expanding healthcare coverage. In the competitive landscape, leading companies such as Glaukos, Alcon, and AbbVie are consolidating their advantages through technological innovations (such as AI-guided navigation and biodegradable stents), while emerging companies are focusing on differentiated indications and cost optimization. Future trends include expanding indications for early intervention, combination use with cataract surgery (expected to account for over 70% of the market share), and accelerated localized production in emerging markets.

This report provides a comprehensive view of the global market for Micro Invasive Glaucoma Surgery (MIGS) Devices, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Micro Invasive Glaucoma Surgery (MIGS) Devices market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Micro Invasive Glaucoma Surgery (MIGS) Devices.

MARKET SEGMENTATION

By Company

Glaukos Corporation
Alcon
AbbVie
iSTAR Medical
New World Medical
Nova Eye Medical
Sight Sciences
HealthGuard Biomed

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

MIGS Stents
MIGS Shunts
Others

Segment by Application

Hospital
Ophthalmology Clinics
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Micro Invasive Glaucoma Surgery (MIGS) Devices manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Micro Invasive Glaucoma Surgery (MIGS) Devices sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Micro Invasive Glaucoma Surgery (MIGS) Devices sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Product Introduction

1.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Forecast

1.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (2021–2032)

1.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (2021–2032)

1.2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Price (2021–2032)

1.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Trends & Drivers

1.3.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Industry Trends

1.3.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Drivers & Opportunities

1.3.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Challenges

1.3.4 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Players Revenue Ranking (2025)

2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Company (2021–2026)

2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Ranking of Players (2025)

2.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Company (2021–2026)

2.5 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Company (2021–2026)

2.6 Key Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturing Base and Headquarters

2.7 Key Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

2.8 Key Manufacturers Start of Mass Production of Micro Invasive Glaucoma Surgery (MIGS) Devices

2.9 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Analysis

2.9.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Micro Invasive Glaucoma Surgery (MIGS) Devices revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Micro Invasive Glaucoma Surgery (MIGS) Devices Market Classification

3.1 Introduction by Type

3.1.1 MIGS Stents

3.1.2 MIGS Shunts

3.1.3 Others

3.1.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type

3.1.4.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, by Type (2021–2032)

3.1.4.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, by Type (%), 2021–2032

3.1.5 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type

3.1.5.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, by Type (2021–2032)

3.1.5.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, by Type (%), 2021–2032

3.1.6 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Ophthalmology Clinics

4.1.3 Others

4.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application

4.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, by Application (2021–2032)

4.2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, by Application (%), 2021–2032

4.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application

4.3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, by Application (2021–2032)

4.3.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, by Application (%), 2021–2032

4.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region

5.1.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (2021–2026)

5.1.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (2027–2032)

5.1.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (%), 2021–2032

5.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region

5.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (2021–2026)

5.2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (2027–2032)

5.2.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (%), 2021–2032

5.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

5.4.2 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

5.5.2 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

5.6.2 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

5.7.2 South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

5.8.2 Middle East & Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value and Sales Volume

6.2.1 Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.2.2 Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.3.2 United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.4.2 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.5.2 China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.5.3 China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.6.2 Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.7.2 South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.8.2 Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021–2032

6.9.2 India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

6.9.3 India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Glaukos Corporation

7.1.1 Glaukos Corporation Company Information

7.1.2 Glaukos Corporation Introduction and Business Overview

7.1.3 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.1.5 Glaukos Corporation Recent Developments

7.2 Alcon

7.2.1 Alcon Company Information

7.2.2 Alcon Introduction and Business Overview

7.2.3 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.2.5 Alcon Recent Developments

7.3 AbbVie

7.3.1 AbbVie Company Information

7.3.2 AbbVie Introduction and Business Overview

7.3.3 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.3.5 AbbVie Recent Developments

7.4 iSTAR Medical

7.4.1 iSTAR Medical Company Information

7.4.2 iSTAR Medical Introduction and Business Overview

7.4.3 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.4.5 iSTAR Medical Recent Developments

7.5 New World Medical

7.5.1 New World Medical Company Information

7.5.2 New World Medical Introduction and Business Overview

7.5.3 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.5.5 New World Medical Recent Developments

7.6 Nova Eye Medical

7.6.1 Nova Eye Medical Company Information

7.6.2 Nova Eye Medical Introduction and Business Overview

7.6.3 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.6.5 Nova Eye Medical Recent Developments

7.7 Sight Sciences

7.7.1 Sight Sciences Company Information

7.7.2 Sight Sciences Introduction and Business Overview

7.7.3 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.7.5 Sight Sciences Recent Developments

7.8 HealthGuard Biomed

7.8.1 HealthGuard Biomed Company Information

7.8.2 HealthGuard Biomed Introduction and Business Overview

7.8.3 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

7.8.5 HealthGuard Biomed Recent Developments

8 Industry Chain Analysis

8.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Industrial Chain

8.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Model

8.5.2 Sales Channels

8.5.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Trends

Table 2. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Drivers & Opportunities

Table 3. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Challenges

Table 4. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Restraints

Table 5. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Company (US$ Million), 2021–2026

Table 6. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Company (2021–2026)

Table 7. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Company (K Units), 2021–2026

Table 8. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Company (US$/Unit), 2021–2026

Table 10. Key Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturing Base and Headquarters

Table 11. Key Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Product Type

Table 12. Key Manufacturers Start of Mass Production of Micro Invasive Glaucoma Surgery (MIGS) Devices

Table 13. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Micro Invasive Glaucoma Surgery (MIGS) Devices revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Value by Type (2021–2026)

Table 20. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Value by Type (2027–2032)

Table 21. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)

Table 22. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type (K Units), 2021–2026

Table 23. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type (K Units), 2027–2032

Table 24. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Type (US$/Unit), 2021–2026

Table 27. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Type (US$/Unit), 2027–2032

Table 28. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Value by Application (2021–2026)

Table 32. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Value by Application (2027–2032)

Table 33. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)

Table 34. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application (K Units), 2021–2026

Table 35. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application (K Units), 2027–2032

Table 36. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Application (US$/Unit), 2021–2026

Table 39. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Application (US$/Unit), 2027–2032

Table 40. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (%), 2021–2026

Table 44. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (%), 2027–2032

Table 45. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (K Units): 2021 vs 2025 vs 2032

Table 46. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (K Units), 2021–2026

Table 47. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (K Units), 2027–2032

Table 48. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (%), 2021–2026

Table 49. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Region (%), 2027–2032

Table 50. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Region (US$/Unit), 2021–2026

Table 51. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Region (US$/Unit), 2027–2032

Table 52. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, (K Units), 2021–2026

Table 56. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume, (K Units), 2027–2032

Table 57. Glaukos Corporation Company Information

Table 58. Glaukos Corporation Introduction and Business Overview

Table 59. Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 60. Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 61. Glaukos Corporation Recent Developments

Table 62. Alcon Company Information

Table 63. Alcon Introduction and Business Overview

Table 64. Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 65. Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 66. Alcon Recent Developments

Table 67. AbbVie Company Information

Table 68. AbbVie Introduction and Business Overview

Table 69. AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 70. AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 71. AbbVie Recent Developments

Table 72. iSTAR Medical Company Information

Table 73. iSTAR Medical Introduction and Business Overview

Table 74. iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 75. iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 76. iSTAR Medical Recent Developments

Table 77. New World Medical Company Information

Table 78. New World Medical Introduction and Business Overview

Table 79. New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 80. New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 81. New World Medical Recent Developments

Table 82. Nova Eye Medical Company Information

Table 83. Nova Eye Medical Introduction and Business Overview

Table 84. Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 85. Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 86. Nova Eye Medical Recent Developments

Table 87. Sight Sciences Company Information

Table 88. Sight Sciences Introduction and Business Overview

Table 89. Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 90. Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 91. Sight Sciences Recent Developments

Table 92. HealthGuard Biomed Company Information

Table 93. HealthGuard Biomed Introduction and Business Overview

Table 94. HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 95. HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Product Offerings

Table 96. HealthGuard Biomed Recent Developments

Table 97. Key Raw Materials Lists

Table 98. Key Suppliers of Raw Materials Lists

Table 99. Micro Invasive Glaucoma Surgery (MIGS) Devices Downstream Customers

Table 100. Micro Invasive Glaucoma Surgery (MIGS) Devices Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Micro Invasive Glaucoma Surgery (MIGS) Devices Product Picture

Figure 2. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 4. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units), 2021–2032

Figure 5. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Price (US$/Unit), 2021–2032

Figure 6. Micro Invasive Glaucoma Surgery (MIGS) Devices Report Years Considered

Figure 7. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Ranking of Players (K Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue in 2025

Figure 10. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. MIGS Stents Picture

Figure 12. MIGS Shunts Picture

Figure 13. Others Picture

Figure 14. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Type (K Units), 2021 vs 2025 vs 2032

Figure 17. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Type (US$/Unit), 2021–2032

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Ophthalmology Clinics

Figure 21. Product Picture of Others

Figure 22. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume by Application (K Units), 2021 vs 2025 vs 2032

Figure 25. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Application (US$/Unit), 2021–2032

Figure 27. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 28. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 30. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 34. South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (%), 2021–2032

Figure 39. United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 40. United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 43. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 45. China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 46. China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 47. China Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 49. Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 57. India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value (US$ Million), 2021–2032

Figure 58. India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Type (%), 2025 vs 2032

Figure 59. India Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Value by Application (%), 2025 vs 2032

Figure 60. Micro Invasive Glaucoma Surgery (MIGS) Devices Industrial Chain

Figure 61. Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Micro Invasive Glaucoma Surgery (MIGS) Devices market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Micro Invasive Glaucoma Surgery (MIGS) Devices market is 11.3% 2026 to 2032.

Which companies rank high in the global Micro Invasive Glaucoma Surgery (MIGS) Devices market? shouQi

What was the global market size of Micro Invasive Glaucoma Surgery (MIGS) Devices in 2026? shouQi

What was the global market size of Micro Invasive Glaucoma Surgery (MIGS) Devices in 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 137
USD 4900.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2026
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 1721 million in 2025 and is anticipated to reach US$ 3603 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 111
USD 2900.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1567 million in 2024 to US$ 3271 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 141
USD 4900.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 92
USD 3950.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 79
USD 4250.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2025
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published Date: 2025-10-17
Pages: 85
USD 2900.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 83
USD 3950.00
(Single User License)
Global and China Micro Invasive Glaucoma Surgery (MIGS) Devices Market Report & Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 94
USD 4350.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 80
USD 3950.00
(Single User License)

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 137
USD 4900.00 (Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
USD 4250.00 (Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2026
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 1721 million in 2025 and is anticipated to reach US$ 3603 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 111
USD 2900.00 (Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1567 million in 2024 to US$ 3271 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 141
USD 4900.00 (Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 92
USD 3950.00 (Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 79
USD 4250.00 (Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2025
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published: 2025-10-17
Pages: 85
USD 2900.00 (Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 83
USD 3950.00 (Single User License)
Global and China Micro Invasive Glaucoma Surgery (MIGS) Devices Market Report & Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 94
USD 4350.00 (Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 80
USD 3950.00 (Single User License)